The sentiment-driven rally also got support from stock specific earning results and Finance Minister Arun Jaitley's statement that the Centre will step up reforms to attract more investment and fill up infrastructure deficit.
The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531.
FMCG, durables, pharma firms say they remain unclear about transition gains and losses
Infosys was the top Sensex loser along with other index heavyweights ITC and HDFC.
The 30-share Sensex ended up 1 point at 27,459 and the 50-share Nifty ended down 1 point at 8,341.
Sensex shed 167 points to close at 28,633 and Nifty dropped 55 points to end at 8,695.
The 30-share Sensex gained 271 points to end at 28,805 and the 50-share Nifty ended up 84 points at 8,712.
The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das.
Impact of the slowdown is most visible among promoter/owner-CEOs
Investors will remain cautious ahead of F&O expiry.
The Sensex ended higher by 245 points at 27,372 mark and the Nifty gained 66 points at 8,225.
The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.
The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.
Benchmark share indices trimmed intra-day gains after global crude oil prices resumed their downward trajectory after sharp gains on Friday.
The S&P BSE Sensex closed 318 points at 24,455 and the Nifty50 shed 99 points to end at 7,438.
The benchmark Nifty rallied 1,000 points or 17% from 7,000 in 78 trading sessions since May 12, till date to surpass the 8,000 mark.
Of these, three stocks belong to the automobile pack and two are from the pharma.
.jpg)
The move is expected to delay the introduction of low-priced medicines in the market.
The 50-issue NSE Nifty in range-bound movements settled higher by 59.15 points, or 0.58 per cent, at 10,252.10.
The Nifty finished the day at 10,265.65, a hefty gain of 98.95 points, or 0.97 per cent, after shuttling between 10,270.85 and 10,195.25.
The wider Nifty hit a low of 10,033.35 before finishing at 10,044.10, down 74.15 points or 0.73 per cent.
Markets extended gains for the fourth consecutive day tracking gains in banks, capital goods and oil and gas majors.
After a volatile session, Sensex closed the day 563 points lower
Sensex remained volatile through the day.
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
Profit booking in realty, oil and gas, capital goods, power and metal stocks pulled the index down to the day's low of 25,347.33 points.
The BSE Sensex gained 104.63 points to end at 33,147.13, while the broader Nifty spurted 48.45 points to finish at 10,343.80.
The benchmark Sensex gained 4,642.84 points, or 16.%, while the broader NSE Nifty surged 1,572.85 points, or 18.20% during this period.
The 30-share Sensex ended down 261 points at 27,177 and the 50-share Nifty ended down 91 points at 8,214.
The recovery was led by pharma majors led by Dr Reddy's Labs.
Shares of RIL ended 2.4% higher as it pips TCS to become most valued firm
FMCG major ITC and private banking major ICICI Bank were the top Sensex losers
The Sensex closed the day at 27,490, higher by 479 points and the Nifty ended at 8331.95, up 150.45 points.
Investors booked profits in recent gainers
The S&P BSE Sensex surged 160 points to close at 25,262.
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
The S&P BSE Sensex dropped 207 points to end at 25,230.
Select metal stocks rebounded while power stocks extended losses after SC verdict on coal block allocations.
In an hour-long chat on rediff.com on Friday, A K Prabhakar, senior VP and Head -- Equity Research (Retail), Anand Rathi Financial Services Ltd, discussed the best stocks to put the investors' money in.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
